Scientists Propose Creating Unique Identification Codes for Biobanks

All biobanks (collections of human biological samples) should be given a unique identification code, EU-funded scientists suggest. Writing in the Journal of the American Medical Association (JAMA), they argue that such a scheme would optimise the use of these resources and open up new avenues for genetics studies.

Biobanks consist of samples of human biological material such as blood or tissue, together with the data associated with them such as clinical information. They are often used in wide-ranging studies designed to identify the genes associated with a particular disease or condition, for example. Ultimately the results of these studies can lead to the development of new treatments.

However, these studies require large numbers of samples to carry out reliable statistical analyses. Obtaining this critical mass of samples would be easier if researchers could find and access data from other biobanks. The problem is that it is currently very difficult to trace biobanks.

To overcome this problem, the authors propose that each biobank be allocated a unique, structured code, similar to the International Standard Book Number (ISBN), which has been used in the book world for over 40 years. The ISBN is made up of a number of elements identifying the language or geographical region, the publisher and the specific edition of the publication.

A similar system could be applied to biobanks, with the different elements identifying the custodian of the biobank, its home country, and the individual collection. If set up along the same lines as the ISBN system, "it would be easy to identify a biological collection, the various surveys in a longitudinal study, or an international programme made of collections built up in various countries," the authors claim.

Biobanks would receive their code at the time of ethical approval, and the system could be applied retroactively to existing studies and collections.

The authors are clear about the advantages offered by their system. Firstly, it would permit individuals to trace the uses made of a given biobank and find out the results generated.

By including information on the collector of the samples and data, such a system could also provide recognition of the hard work involved in building up a biobank.

The registration number could also be given to study participants, enabling them to follow the use of the collection and see how their sample and data are being used, even if they are anonymised.

Some questions still remain to be answered, such as who would maintain the system, who would fund it, and how uptake would be ensured.

The EU projects supporting the proposal are: GA2LEN ('Global allergy and asthma European network') and PHOEBE ('Promoting the harmonisation of epidemiological biobanks in Europe'), both of which are financed under the Sixth Framework Programme, and GEN2PHEN ('Genotype to phenotype databases: a holistic solution') and BBMRI ('Biobanking and biomolecular resources research infrastructure'), both of which are funded through the Seventh Framework Programme (FP7).

For further information, please visit:
http://www.jama.com

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...